Now half way through the year, Detroit-based Henry Ford Health is still reaping the rewards of a financially sound fiscal 2024, after seeing a major leap in operating income last year, up to $294.2 million from $80.5 million in 2023.…
The Latest
In the next six years, U.S. health systems will spend more than $2 billion on infrastructure projects to accommodate the rapidly changing cancer care landscape. While incidence levels among young adults continue to rise, researchers are uncovering innovative ways to…
President Donald Trump said he will most likely impose tariffs on pharmaceuticals as soon as the end of the month, along with tariffs on semiconductors, Bloomberg reported July 15. Here are four notes:
The healthcare sector reported 283 data breaches in the first half of 2025, up from 236 during the same period in 2024, according to a July 16 report from the Identity Theft Resource Center. Here are four things to know…
In May, New York City-based Mount Sinai established the Steven S. Elbaum Family Center for Caregiving, a support center dedicated to the psychological needs of caregivers. The center, made possible by a gift from Trudy Elbaum Gottesman and Robert Gottesman…
Murray-Calloway County Hospital in Murray, Ky., has named Brian Craven CFO. In his new role, Mr. Craven, who has more than 25 years of financial healthcare experience, will lead financial operations for the hospital, including budgeting, financial reporting and revenue…
Rochester, Minn.-based Mayo Clinic is adding improv comedy classes to its medical residents’ training to improve the physician-patient relationship, NPR reported July 16. The improv workshop teaches skills that can’t be learned from a textbook, a participating resident told the…
CMS has reached agreements with drug manufacturers to provide gene therapies to treat sickle cell disease to Medicaid recipients under a new outcomes-based model. A total of 33 states, including the District of Columbia and Puerto Rico, have joined a…
This episode features Dave Lamar, Chief Growth Officer at MediQuant, discussing how healthcare organizations can use data-driven onboarding and standardized retention strategies to reduce costs, ensure compliance, and improve the patient experience during system transitions. He also shares insights on…
The FDA is reevaluating GlaxoSmithKline’s blood cancer drug Blenrep following mixed results from two phase 3 trials and mounting concerns about eye-related side effects and dosing. The agency is meeting with its Oncologic Drugs Advisory Committee July 17 to discuss…